Mike Bastian

Company: Sanofi Genzyme

Job title: Medical Manager Atopic Dermatitis

Seminars:

Dupilumab: The First Approved Biologic for Atopic Dermatitis 3:20 pm

Shining light on the rationale for biologic development during a wave of JAK inhibitor development Transforming quality of life for patients by tackling chronic itch Looking forward into bringing dupilumab into other dermatological indicationsRead more

day: Day Two